Parallel Session: NAFLD and NASH: Prognostic and Diagnostic Methods

Watch this live session to see some the top research in NAFLD and NASH. Content will only be aired on this date, at this time. Don't miss it!

• Diagnostic Accuracy of MRI Biomarkers cT1 and FAT for High-Risk Non-Alcoholic Steatohepatitis
  Presenting Author Andrea Dennis
• Noninvasive Assessments to Identify Patients with Advanced Fibrosis Due to NASH: Screened Population From the Regenerate Trial
  Presenting Author Jerome Boursier
• GEMS, A Genetic Metabolic Staging Predicting the Outcome of Non-Alcoholic Fatty Liver Disease
• A Randome Forest Classifier Based on a 30-Gene Signature Distinguishes Patients with Bridging Fibrosis from those with Cirrhosis Due to NASH
  Presenting Author Yevgeniy Gindin
• Whole-Transcription Cell-Free Messenger RNA Characterization of Non-Alcoholic Fatty Liver Diease
  Presenting Author Naga Chalasani
• Clinical Characteristics Used for Machine Learning Idenitification of Fast Progressors Among Patients with NASH
  Presenting Author Jörn Schattenberg